(±)-Asenapine-13C-d3 (hydrochloride) – 1 mg

Brand:
Cayman
CAS:
1261392-55-5
Storage:
-20
UN-No:
Non-Hazardous - /

(±)-Asenapine-13C-d3 is intended for use as an internal standard for the quantification of (±)-asenapine (Item No. 9000496) by GC- or LC-MS. (±)-Asenapine is an atypical antipsychotic.{41915,41916} It binds to dopamine D1-4, α-adrenergic, and histamine receptors (Kis = 0.42-1.45, 0.32-1.26, and 1-6.17 nM, respectively), as well as the serotonin (5-HT) receptor subtypes 5-HT1A, 5-HT1B, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT5A, 5-HT6, and 5-HT7 (Kis = 0.03-3.98 nM).{41916} (±)-Asenapine inhibits the suppression of neuron firing induced by the 5-HT2A, dopamine D2, and α2-adrenergic receptor agonists 2,5-dimethoxy-4-iodoamphetamine (DOI), apomorphine, and clonidine (Item No. 15949), respectively, in rat brain (ED50s = 75, 40, and 85 μg/kg, respectively).{41915} In vivo, (±)-asenapine (0.05-0.2 mg/kg, s.c.) increases extracellular dopamine levels in the medial prefrontal cortex (mPFC), nucleus accumbens (NAc), and lateral striatum and suppresses the conditioned avoidance response in rats.{41917} It prevents acute and chronic phencyclidine-induced deficits in cued reversal learning in rats when administered at a dose of 0.075 mg/kg.{41918} Formulations containing asenapine have been used in the treatment of schizophrenia and bipolar I disorder.  

 

Available on backorder

SKU: 31980 - 1 mg Category:

Description

An internal standard for the quantification of (±)-asenapine by GC- or LC-MS


Formal name: (3aR,12bR)-rel-5-chloro-2,3,3a,12b-tetrahydro-2-(methyl-13C-d3)-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole, monohydrochloride

Synonyms: 

Molecular weight: 326.2

CAS: 1261392-55-5

Purity: ≥99% deuterated forms (d1-d3)

Formulation: A solid